Cartesian Therapeutics Inc (RNAC)

Cartesian Therapeutics Inc Azioni (RNAC) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	0.08	0.95	0.45
	14.25%25.00	29.16	26.58	79.59	21.52
Research and Development	23.53%15.62	20.43	19.46	14.69	13.80
Operating Income/Loss	14.25%-25.00	-29.16	-26.50	-78.64	-21.07
Nonoperating Income/Loss	69.88%13.53	44.92	-12.68	-	-
	172.75%-11.47	15.77	-39.18	-92.58	-35.90
Attributable To Parent	172.75%-11.47	15.77	-39.18	-92.58	-35.90
Basic Average Shares	2.86%30.31	29.47	26.86	0.01	26.00
Diluted Average Shares	1.50%30.31	29.86	26.86	0.01	26.00
Basic Earnings Per Share	180.85%-0.38	0.47	-1.46	-3.57	-1.38
Diluted Earnings Per Share	182.61%-0.38	0.46	-1.46	-3.57	-1.38